Intravenous Immunoglobulin for Treatment of Mild-To-Moderate Alzheimer's Disease: A Phase 2, Randomised, Double-Blind, Placebo-Controlled, Dose-Finding Trial

AuthID
P-00F-XQR
23
Author(s)
Dodel, R
·
Rominger, A
·
Bartenstein, P
·
Blennow, K
·
Forster, S
·
Winter, Y
·
Bach, JP
·
Popp, J
·
Alferink, J
·
[+3]·
Jacoby, M
·
Richter, R
·
Stevens, J
·
Melamed, I
·
Goldstein, J
·
Haag, S
·
Wietek, S
·
Farlow, M
·
Jessen, F
Document Type
Article
Year published
2013
Published
in The Lancet Neurology, ISSN: 1474-4422
Volume: 12, Issue: 3, Pages: 233-243
Indexing
Publication Identifiers
Pubmed: 23375965
Scopus: 2-s2.0-84876307732
Source Identifiers
ISSN: 1474-4422
Export Publication Metadata
Marked List
Info
At this moment we don't have any links to full text documens.
Name Order Name   Name Order Name   Name Order Name
1 Dodel, R;   2 Rominger, A;   3 Bartenstein, P;
4 Barkhof, F;   5 Blennow, K;   6 Forster, S;
7 Winter, Y;   8 Bach, JP;   9 Popp, J;
10 Alferink, J;   11 Wiltfang, J;   12 Buerger, K;
13 Otto, M;   14 Antuono, P;   15 Jacoby, M;
16 Richter, R;   17 Stevens, J;   18 Melamed, I;
19 Goldstein, J;   20 Haag, S;   21 Wietek, S;
22 Farlow, M;   23 Jessen, F;